Orchestra BioMed Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Orchestra BioMed Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2024.
  • Orchestra BioMed Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.33M, a 29% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.33M -$543K -29% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.5M -$531K -26.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.56M -$632K -28.9% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $1.71M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.87M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.03M Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.19M Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.